Association of mitochondrial iron deficiency and dysfunction with idiopathic restless legs syndrome

Restless legs syndrome is a sensorimotor neurological disorder of the limbs that impairs quality of life and disturbs sleep. However, there has been progress in understanding the disease involving the dopaminergic system as well as iron metabolism. The exact pathophysiological mechanisms of restless legs syndrome remain elusive. We tried to elucidate the underlying mechanisms in iron metabolism in restless legs syndrome subjects on a systemic, cellular, and mitochondrial level.

[1]  G. Weiss,et al.  Dopamine promotes cellular iron accumulation and oxidative stress responses in macrophages , 2018, Biochemical pharmacology.

[2]  W. Oertel,et al.  Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial , 2017, Movement disorders : official journal of the Movement Disorder Society.

[3]  J. Connor,et al.  Iron and restless legs syndrome: treatment, genetics and pathophysiology. , 2017, Sleep medicine.

[4]  M. Selim,et al.  Heme oxygenase-1-mediated neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine , 2016, Journal of Neuroinflammation.

[5]  P. V. van Zijl,et al.  Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla. , 2016, Sleep medicine.

[6]  W. Paulus,et al.  Restless legs syndrome associated with major diseases , 2016, Neurology.

[7]  R. Allen.  Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology. , 2015, Sleep medicine clinics.

[8]  Sebastian Wienerroither,et al.  Contrasting regulation of macrophage iron homeostasis in response to infection with Listeria monocytogenes depending on localization of bacteria. , 2015, Metallomics : integrated biometal science.

[9]  J. Jankovic,et al.  Restless legs syndrome: clinical presentation diagnosis and treatment. , 2015, Sleep medicine.

[10]  C. Camaschella.  Iron-deficiency anemia. , 2015, The New England journal of medicine.

[11]  D. Richardson,et al.  Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease. , 2015, Biochimica et biophysica acta.

[12]  G. Weiss,et al.  'Ride on the ferrous wheel'--the cycle of iron in macrophages in health and disease. , 2015, Immunobiology.

[13]  C. Gieger,et al.  Heme Oxygenase-1 Gene Promoter Microsatellite Polymorphism Is Associated With Progressive Atherosclerosis and Incident Cardiovascular Disease , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[14]  J. Connor,et al.  Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease). , 2014, Sleep medicine.

[15]  Richard P Allen,et al.  Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. , 2014, Sleep medicine.

[16]  J. Winkelmann,et al.  Restless legs syndrome: update on pathogenesis , 2013, Current opinion in pulmonary medicine.

[17]  Shih-Yi Lin,et al.  Shorter GT repeats in the heme oxygenase‐1 gene promoter are associated with a lower severity score in coronary artery disease , 2013, Journal of the Chinese Medical Association : JCMA.

[18]  C. Gieger,et al.  Dilution of candidates: the case of iron-related genes in restless legs syndrome , 2012, European Journal of Human Genetics.

[19]  L. Kühn,et al.  Metabolic adaptation to tissue iron overload confers tolerance to malaria. , 2012, Cell host & microbe.

[20]  D. Rye,et al.  Restless legs syndrome and periodic leg movements of sleep. , 2012, Neurologic clinics.

[21]  James B. Mitchell,et al.  Iron Insufficiency Compromises Motor Neurons and Their Mitochondrial Function in Irp2-Null Mice , 2011, PloS one.

[22]  Jian Wang,et al.  Regulation of cellular iron metabolism , 2011, The Biochemical journal.

[23]  M. Hentze,et al.  Iron regulatory proteins secure mitochondrial iron sufficiency and function. , 2010, Cell metabolism.

[24]  Matthias W. Hentze,et al.  Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.

[25]  D. Richardson,et al.  The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich’s ataxia , 2010, Journal of Molecular Medicine.

[26]  J. Connor,et al.  Mitochondrial Ferritin in the Substantia Nigra in Restless Legs Syndrome , 2009, Journal of neuropathology and experimental neurology.

[27]  D. Richardson,et al.  Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant , 2009, Proceedings of the National Academy of Sciences.

[28]  R. Lill.  Function and biogenesis of iron–sulphur proteins , 2009, Nature.

[29]  T. Rouault,et al.  Tangled up in red: intertwining of the heme and iron-sulfur cluster biogenesis pathways. , 2009, Cell metabolism.

[30]  C. Datz,et al.  Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. , 2009, Blood.

[31]  D. Taub,et al.  Altered iron metabolism in lymphocytes from subjects with restless legs syndrome. , 2008, Sleep.

[32]  H. Niederegger,et al.  Autocrine formation of hepcidin induces iron retention in human monocytes. , 2008, Blood.

[33]  N. Andrews,et al.  Iron homeostasis. , 2007, Annual review of physiology.

[34]  R. Allen,et al.  The role of iron in restless legs syndrome , 2007, Movement disorders : official journal of the Movement Disorder Society.

[35]  R. Allen,et al.  MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. , 2006, Sleep medicine.

[36]  T. Ganz,et al.  Regulation of iron metabolism by hepcidin. , 2006, Annual review of nutrition.

[37]  F. Bach,et al.  Heme oxygenase‐1: a therapeutic amplification funnel , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  E. Meyron-Holtz,et al.  Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2. , 2005, Blood.

[39]  J. Connor,et al.  Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome , 2004, Neurology.

[40]  A. Uitterlinden,et al.  Fundamental Role for HO‐1 in the Self‐Protection of Renal Allografts , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  J. Connor,et al.  Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome , 2003, Neurology.

[42]  G. Minotti,et al.  The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. , 2002, Free radical biology & medicine.

[43]  E. Gnaiger,et al.  Bioenergetics at low oxygen: dependence of respiration and phosphorylation on oxygen and adenosine diphosphate supply. , 2001, Respiration physiology.

[44]  J. Connor,et al.  Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome , 2000, Neurology.

[45]  G. Weiss,et al.  Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. , 1999, Biochimica et biophysica acta.

[46]  S. O’Keeffe,et al.  Iron status and restless legs syndrome in the elderly. , 1994, Age and ageing.

[47]  S. Akpinar.  Treatment of restless legs syndrome with levodopa plus benserazide. , 1982, Archives of neurology.

[48]  K. Ekbom.  Restless legs syndrome , 1960, Neurology.

[49]  N. Nordlander.  Therapy in restless legs. , 2009, Acta medica Scandinavica.